MAP3K5 and neoplasm: CLDN6 is therefore suggested to function as a tumor suppressor by inhibiting malignant phenotype of breast cancer cells through various signaling pathways such as p38-MAPK, JAKs-STATs, ASK1-JNK, and other pathways [4, 5].